Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

A study recently published in the journal Cureus has described a case report of a coronavirus disease 2019 (COVID-19) patient who presented with pneumonia, posterior reversible encephalopathy syndrome (PRES), and persistent cortical blindness. A detailed clinical presentation of the patient is provided in the report.

31 Jan 2021

COVID effect resulted in substantial decline in heart surgery, caused more patient deaths

The most deadly global health crisis in a century has resulted in a substantial decline in overall heart surgery volume and an unexplained increase in deaths after coronary artery bypass grafting, according to late-breaking research presented at the 57th Annual Meeting of The Society of Thoracic Surgeons.

31 Jan 2021

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

A recent US study, currently available on medRxiv preprint server, supports a beneficial rather than immunopathologic role for effector T-cells during serious infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) –

31 Jan 2021

COVID-19 decreased access to school meals, exacerbated food insecurity among children

School closures during COVID-19 have decreased access to school meals, which is likely to increase the risk for food insecurity among children in Maryland, according to a new report issued by researchers at the University of Maryland School of Medicine (UMSOM).

30 Jan 2021

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

30 Jan 2021

Research identifies and explores the impacts of emergent COVID-19 behavioral identities

New research by Mimi E. Lam (University of Bergen) just published in Humanities and Social Sciences Communications identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.

30 Jan 2021

Researchers examine the connection between lung cancer and COVID-19

On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.

30 Jan 2021

Survey: More than a third of Americans either unlikely or unsure to get a COVID-19 vaccine

News reports indicate COVID-19 vaccines are not getting out soon enough nor in adequate supplies to most regions, but there may be a larger underlying problem than shortages. A University of California, Davis, study found that more than a third of people nationwide are either unlikely or at least hesitant to get a COVID-19 vaccine when it becomes available to them.

30 Jan 2021

Startup develops yeast-based test to detect the presence of SARS-CoV-2 in saliva

Incubated at the University of Campinas (UNICAMP) in the state of São Paulo, Brazil, and supported by São Paulo Research Foundation- FAPESP's Innovative Research in Small Business Program (PIPE), BIOinFOOD is a startup that is developing a rapid COVID-19 diagnostic test based on a patent application filed by students at UNICAMP's Genomics and Bioenergy Laboratory.

29 Jan 2021

New forecasts show possibility of spike in COVID-19 cases and deaths in the spring

The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at the University of Washington now incorporate two new virus variants.

29 Jan 2021

County-level sociodemographic risk factors associated with COVID-19 incidence and mortality

In just one year, COVID-19 has killed more than 400,000 Americans, and infected more than 24 million others. But a new study shows just how unevenly those deaths and cases have played out across the country.

29 Jan 2021

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

As we endure a global viral pandemic, our appreciation for health and immunity has never been greater. Now, thanks to a generous gift from the NOMIS Foundation, Salk's NOMIS Center for Immunobiology and Microbial Pathogenesis will receive $9.5 million to grow and expand, while continuing to be a leader in health and immunity research.

29 Jan 2021

New COVID-19 test uses a smartphone microscope to quickly analyze saliva samples

Researchers at the University of Arizona are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.

29 Jan 2021

Researchers explore adaptive immunity against human coronaviruses

A recent study shows that long-term adaptive immunity to endemic coronaviruses is widespread, but low in magnitude, and that it shares phenotypic features of spike-specific antibodies and T cell memory across all tested coronaviruses.

29 Jan 2021

What are the main drivers of COVID-19 vaccine hesitancy?

A study conducted in the UK has examined attitudes towards vaccination protecting against COVID-19 and highlighted some of the main drivers of willingness or unwillingness to be immunized.

29 Jan 2021

U.S. public divided over COVID-19 “immunity passports” idea

A nationally representative survey conducted in the U.S. suggests that the public is fairly evenly divided in its support of immunity certificates or “passports” to enable the selective lifting of restrictions placed on people during the COVID-19 pandemic.

29 Jan 2021

What are the natural origins of SARS-CoV-2?

Researchers from the UK and China performed a comprehensive analysis of horseshoe bat and pangolin Sarbecoviruses to shed light on the origins of SARS-CoV-2.

29 Jan 2021

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation.

29 Jan 2021

Vitamins and other antiviral drugs may help combat COVID-19

Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work.

29 Jan 2021

Pandemic sends a couple into indefinite long distance though just miles apart

Every Sunday afternoon, Suzan Mubarak keeps an eye on her phone. That is when her boyfriend will call to let her know he's outside her house for their weekly wave.

29 Jan 2021

Pandemic News and Research

Further Reading

Complication of severe SARS-CoV-2 pneumonia results in persistent cortical blindness: Case report

COVID effect resulted in substantial decline in heart surgery, caused more patient deaths

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

COVID-19 decreased access to school meals, exacerbated food insecurity among children

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

Research identifies and explores the impacts of emergent COVID-19 behavioral identities

Researchers examine the connection between lung cancer and COVID-19

Survey: More than a third of Americans either unlikely or unsure to get a COVID-19 vaccine

Startup develops yeast-based test to detect the presence of SARS-CoV-2 in saliva

New forecasts show possibility of spike in COVID-19 cases and deaths in the spring

County-level sociodemographic risk factors associated with COVID-19 incidence and mortality

Salk's NOMIS Center receives $9.5 million to grow and expand in health, immunity research

New COVID-19 test uses a smartphone microscope to quickly analyze saliva samples

Researchers explore adaptive immunity against human coronaviruses

What are the main drivers of COVID-19 vaccine hesitancy?

U.S. public divided over COVID-19 “immunity passports” idea

What are the natural origins of SARS-CoV-2?

New gene-based vaccine strategy receives grant from the Bill & Melinda Gates Foundation

Vitamins and other antiviral drugs may help combat COVID-19

Pandemic sends a couple into indefinite long distance though just miles apart

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News